AMGN – amgen inc. (US:NASDAQ)
Stock Stats
News
Amgen (AMGN) had its "neutral" rating reaffirmed by Cantor Fitzgerald. They now have a $350.00 price target on the stock.
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE [Yahoo! Finance]
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE [TheStreet.com]
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Form DEFA14A AMGEN INC
Form DEF 14A AMGEN INC For: May 19
Form ARS AMGEN INC For: Dec 31
Form SCHEDULE 13G/A AMGEN INC Filed by: VANGUARD GROUP INC
Form 4 AMGEN INC For: Mar 16 Filed by: Santos Esteban
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.